3SBio Inc
HKEX:1530
3SBio Inc
HKEX:1530
Price:
6.8 HKD
3.34%
Market Closed
Updated:
May 4, 2024
3SBio Inc
Operating Income
|
3SBio Inc
Operating Income Peer Comparison
Comparables:
6160
1801
603392
300122
300896
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
3SBio Inc
HKEX:1530
|
Operating Income
¥2.5B
|
CAGR 3-Years
21%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Operating Income
-¥12B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Income
-¥1.1B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Income
¥1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Income
¥9.9B
|
CAGR 3-Years
38%
|
CAGR 5-Years
46%
|
CAGR 10-Years
47%
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Income
¥1.4B
|
CAGR 3-Years
59%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
See Also
What is 3SBio Inc's Operating Income?
Operating Income
2.5B
CNY
2.5B
CNY
Based on the financial report for Dec 31, 2023, 3SBio Inc's Operating Income amounts to 2.5B CNY.
What is 3SBio Inc's Operating Income growth rate?
Operating Income CAGR 5Y
14%
14%
Over the last year, the Operating Income growth was 4%. The average annual Operating Income growth rates for 3SBio Inc have been 21% over the past three years , 14% over the past five years .
You don't have any saved screeners yet
